I agree that this site is using cookies. You can find further informations here.
X
Mahlangu, Johnny N
153  results:
Search for persons X
?
1

Treatment with Marstacimab for People with Severe Hemophili..:

Mahlangu, Johnny N ; Lamas, Jose Luis ; Morales, Juan Cristobal...
Future Rare Diseases.  3 (2023)  4 - p. , 2023
Link: https://doi.org/10.2217/..
 
?
2

Managing surgery in hemophilia with recombinant factor VIII..:

Chowdary, Pratima ; Holmström, Margareta ; Mahlangu, Johnny N....
Research and Practice in Thrombosis and Haemostasis.  6 (2022)  5 - p. e12760 , 2022
Link: https://doi.org/10.1002/..
 
?
3

A phase 1b/2 clinical study of marstacimab, targeting human..:

Mahlangu, Johnny N. ; Lamas, Jose Luis ; Morales, Juan Cristobal...
British Journal of Haematology.  200 (2022)  2 - p. 229-239 , 2022
Link: https://doi.org/10.1111/..
 
?
4

Development and testing of the Satisfaction Questionnaire w..:

Kempton, Christine ; Trask, Peter ; Parnes, Aric...
Haemophilia.  27 (2021)  2 - p. 221-228 , 2021
Link: https://doi.org/10.1111/..
 
?
5

Patient preference for emicizumab versus prior factor thera..:

Parnes, Aric ; Mahlangu, Johnny N. ; Pipe, Steven W....
Haemophilia.  27 (2021)  6 - p. , 2021
Link: https://doi.org/10.1111/..
 
?
6

Progress in the Development of Anti-tissue Factor Pathway I..:

Mahlangu, Johnny N.
Frontiers in Medicine.  8 (2021)  - p. , 2021
Link: https://doi.org/10.3389/..
 
?
7

The changing treatment landscape in haemophilia: from stand..:

Mancuso, Maria Elisa ; Mahlangu, Johnny N ; Pipe, Steven W
The Lancet.  397 (2021)  10274 - p. 630-640 , 2021
Link: https://doi.org/10.1016/..
 
?
8

Application of a hemophilia mortality framework to the Emic..:

Peyvandi, Flora ; Mahlangu, Johnny N. ; Pipe, Steven W....
Journal of Thrombosis and Haemostasis.  19 (2021)  - p. 32-41 , 2021
Link: https://doi.org/10.1111/..
 
?
9

Establishment of a framework for assessing mortality in per..:

Pipe, Steven W. ; Kruse‐Jarres, Rebecca ; Mahlangu, Johnny N....
Journal of Thrombosis and Haemostasis.  19 (2021)  - p. 21-31 , 2021
Link: https://doi.org/10.1111/..
 
?
10

Health‐related quality of life and health status in adolesc..:

Oldenburg, Johannes ; Tran, Huyen ; Peyvandi, Flora...
Haemophilia.  27 (2021)  3 - p. 398-407 , 2021
Link: https://doi.org/10.1111/..
 
?
11

A new hemophilia carrier nomenclature to define hemophilia ..:

van Galen, Karin P.M. ; d'Oiron, Roseline ; James, Paula...
Journal of Thrombosis and Haemostasis.  19 (2021)  8 - p. 1883-1887 , 2021
Link: https://doi.org/10.1111/..
 
?
12

Redefining prophylaxis in the modern era:

Mahlangu, Johnny N. ; Blanchette, Victor ; Klamroth, Robert
Haemophilia.  27 (2020)  S3 - p. 21-27 , 2020
Link: https://doi.org/10.1111/..
 
?
13

Requirements to participate in haemophilia clinical trials:

Mahlangu, Johnny N.
Haemophilia.  26 (2020)  S3 - p. 22-25 , 2020
Link: https://doi.org/10.1111/..
 
?
14

Bispecific Antibody Emicizumab for Haemophilia A: A Breakth..:

Mahlangu, Johnny N.
BioDrugs.  32 (2018)  6 - p. 561-570 , 2018
Link: https://doi.org/10.1007/..
 
?
15

BAY 81-8973, a full-length recombinant factor VIII for the ..:

Mahlangu, Johnny N. ; Ahuja, Sanjay P. ; Windyga, Jerzy...
Therapeutic Advances in Hematology.  9 (2018)  7 - p. 191-205 , 2018
Link: https://doi.org/10.1177/..
 
1-15